Conformational dynamics of auto-inhibition in the ER calcium sensor STIM1

  1. Stijn van Dorp
  2. Ruoyi Qiu
  3. Ucheor B Choi
  4. Minnie M Wu
  5. Michelle Yen
  6. Michael Kirmiz
  7. Axel T Brunger
  8. Richard S Lewis  Is a corresponding author
  1. Department of Molecular and Cellular Physiology, Stanford University School of Medicine, United States
  2. Howard Hughes Medical Institute, Stanford University School of Medicine, United States
9 figures, 1 table and 4 additional files

Figures

Figure 1 with 3 supplements
Parallel orientation of CC2 domains in ctSTIM1 is consistent with the CAD crystal structure.

(A) (top) Schematic overview of domains in ctSTIM1, comprising the membrane-proximal coiled-coil 1 (CC1) domain with helical regions α1 (aa 238–271), α2 (aa 278–304), and α3 (aa 308–337), and the …

Figure 1—figure supplement 1
smFRET histograms for CAD measurements.

Peaks of the histograms are indicated by arrows and represent the predominant ctSTIM1 conformation. The locations of the measurement sites are indicated on a model of ctSTIM1 for each sample. Legend …

Figure 1—figure supplement 1—source data 1

Time series of donor and acceptor fluorescence and FRET for single molecules.

https://cdn.elifesciences.org/articles/66194/elife-66194-fig1-figsupp1-data1-v2.xlsx
Figure 1—figure supplement 2
smFRET histograms for CC1 measurements.

Peaks of the histograms are indicated by arrows and represent the predominant ctSTIM1 conformation. The locations of the measurement sites are indicated on a model of ctSTIM1 for each sample. Legend …

Figure 1—figure supplement 2—source data 1

Time series of donor and acceptor fluorescence and FRET for single molecules.

https://cdn.elifesciences.org/articles/66194/elife-66194-fig1-figsupp2-data1-v2.xlsx
Figure 1—figure supplement 3
smFRET histograms for CC1:CAD measurements.

Peaks of the histograms are indicated by arrows and represent the predominant ctSTIM1 conformation. The locations of the measurement sites are indicated on a model of ctSTIM1 or CAD for each sample. …

Figure 1—figure supplement 3—source data 1

Time series of donor and acceptor fluorescence and FRET for single molecules.

https://cdn.elifesciences.org/articles/66194/elife-66194-fig1-figsupp3-data1-v2.xlsx
Figure 2 with 1 supplement
The apex of CAD in ctSTIM1 deviates from the CAD crystal structure.

(A) Representative smFRET recording at the base of CAD (431:431´) showing stable, high FRET. (B) Ensemble density plots of the initial 2 s of inter-subunit smFRET recordings for sites throughout …

Figure 2—figure supplement 1
CAD apex structure.

(A) Dimerization of ctSTIM1 cysteine mutants by disulfide bond formation in CAD, shown by non-reducing SDS-PAGE. CuP-induced dimerization was virtually absent at basal sites but was evident at all …

Figure 2—figure supplement 1—source data 1

Raw unedited gel for Figure 2—figure supplement 1A (ctSTIM1 CAD cysteine crosslinking).

https://cdn.elifesciences.org/articles/66194/elife-66194-fig2-figsupp1-data1-v2.zip
Figure 2—figure supplement 1—source data 2

Uncropped labeled gel for Figure 2—figure supplement 1A (ctSTIM1 CAD cysteine crosslinking).

https://cdn.elifesciences.org/articles/66194/elife-66194-fig2-figsupp1-data2-v2.zip
Figure 3 with 1 supplement
The CC1α1 domain is near and parallel to the CC3 domain of the opposing CAD subunit.

(A) Asymmetric inter-subunit smFRET measurements between CC1α1 and CC3 reveal a parallel orientation, with high FRET levels at 242:400´ (top, red) and 274:431´ (bottom, blue) indicating close …

Figure 3—figure supplement 1
CC1α1:CAD dynamics.

(A) Schematic drawing of the measurement sites for inter-subunit smFRET measurements from aa 242 in CC1α1 to sites 400´, 417´, and 431´ in CC3´ (left). An example recording of smFRET transitions at …

Figure 3—figure supplement 1—source data 1

Time series of FRET, Hidden-Markov Model fits, and state clusters for single molecules.

https://cdn.elifesciences.org/articles/66194/elife-66194-fig3-figsupp1-data1-v2.xlsx
Figure 4 with 1 supplement
The CC1α2 and CC1α3 domains are closely apposed and directed away from CAD.

(A) High inter-subunit smFRET at the N- and C-termini of the CC1α3 domain (aa 312 and 337, respectively) indicates close parallel apposition of the two helices. The crystal structure of CAD is shown …

Figure 4—figure supplement 1
CC1α3:CC1α3´ dynamics.

(A) Schematic drawing of inter-subunit smFRET measurement sites near the CC1α3 N-terminus. (B) Example traces at aa 307 (top), 309 (center), and 312 (bottom) show large-amplitude fluctuations from …

Figure 4—figure supplement 1—source data 1

Time series of FRET, Hidden-Markov Model fits, and state clusters for Figure 4—figure supplement 1.

https://cdn.elifesciences.org/articles/66194/elife-66194-fig4-figsupp1-data1-v2.xlsx
Figure 5 with 3 supplements
smFRET-derived models of the configuration of CC1 and CAD in ctSTIM1.

(A) 36 smFRET-derived distances were used to reconstruct the orientations of CC1 domains relative to CAD, yielding two classes of solutions with the CC1α2/α3 domains in a ’stacked' (left) or …

Figure 5—figure supplement 1
CC1-CAD models.

smFRET-constrained modeling produced two different topologies for stacking of the CC1α2/α3 domains. For both classes of solutions, the orientation of CC1α1 parallel to CC3 on the adjacent subunit …

Figure 5—figure supplement 2
Mass spectrometry analysis of ctSTIM1 crosslinking by BS3.

(A) SDS-PAGE of wild-type and mutant ctSTIM1 treated with BS3 to induce lysine-lysine crosslinking. Wild-type ctSTIM1 was treated with BS3-d0 as a reference, and four different ctSTIM1 variants were …

Figure 5—figure supplement 3
Mass spectrometry analysis of ctSTIM1 crosslinking by EDC.

(A) SDS-PAGE analysis of ctSTIM1 treated with zero-length amine-carboxyl crosslinker EDC. Monomer (blue) and dimer (red) bands were cut from the gel for analysis by mass spectrometry. For the …

Figure 6 with 1 supplement
The Stormorken R304W mutation releases CC1 from CAD.

(A) The R304W mutation reduced inter-subunit smFRET between aa 242 on CC1α1 and sites 400´, 417´, and 431´ on CC3´, indicating separation of CC1α1 from CAD. The mutation also reduced intra-subunit …

Figure 6—figure supplement 1
Orai1-mediated Ca2+ influx evoked by ctSTIM1 fragments.

HEK293 cells expressing the indicated ctSTIM1 variant and Orai1-GFP were exposed sequentially to 2 mM Ca2+, 0 Ca2+, and 2 mM Ca2+. The fura-2 350/380 fluorescence ratio is shown for ctSTIM1 (aa …

Figure 7 with 2 supplements
Close pairing of CC1 domains along their entire length in the activated state of full-length STIM1 (flSTIM1) in vivo.

(A) Western-blot analysis of diamide-induced cysteine crosslinking of flSTIM1-WT, flSTIM1-A268C, flSTIM1-T307C and flSTIM1-S339C in HEK293 cells, under resting (2 mM Ca2+) or store-depleted (0 mM Ca2…

Figure 7—source data 1

Raw unedited and uncropped labeled western blots for Figure 7A (WT).

https://cdn.elifesciences.org/articles/66194/elife-66194-fig7-data1-v2.zip
Figure 7—figure supplement 1
CC1 cysteine crosslinking in ctSTIM1 and flSTIM1.

(A) Cysteine crosslinking throughout the CC1 domain of ctSTIM1 mutants in vitro produced by copper phenanthroline and detected by non-reducing SDS-PAGE (see Materials and methods). Crosslinking …

Figure 7—figure supplement 1—source data 1

Raw unedited and uncropped labeled gel and western blots for Figure 7—figure supplement 1.

https://cdn.elifesciences.org/articles/66194/elife-66194-fig7-figsupp1-data1-v2.zip
Figure 7—figure supplement 2
Mass spectrometry analysis of BS3 crosslinking of active ctSTIM1 mutants.

Mass-spectrometry analysis of ctSTIM1 variants 2LS (L248S + L251S, B), R304W (C), and T307C (D) showed similarly altered link patterns relative to WT (A). Crosslinked residue pairs for each sample …

Figure 7—figure supplement 2—source data 1

List of crosslinked residues from mass spectrometry.

https://cdn.elifesciences.org/articles/66194/elife-66194-fig7-figsupp2-data1-v2.xlsx
Possible conformational trajectories of flSTIM1 activation in vivo.

(A) In the resting state, the parallel orientation of CC1α1 and CC3 domains implies that CAD is held with its apex close to and pointed towards the ER membrane, effectively shielding critical …

Author response image 1
Dimers of flSTIM1 show anomalously low mobility in SDS-PAGE.

Purified flSTIM1 was treated with 0.1 mM diamide for 10 min. In lane 2, 10 mM TCEP (reducing agent) was added to the crosslinked sample 10 min before running the gel. Coomassie blue SDS-PAGE with MW …

Tables

Key resources table
Reagent type (species) or resourceDesignationSource or referenceIdentifiersAdditional information
Gene (human)STIM1Origene
Strain, strain background (Escherichia coli)BL21New England BiolabsC25271
Strain, strain background (Escherichia coli)CVB101AvidityCVB101
Cell line (human)HEK293ATCCCRL-1573
AntibodyMouse monoclonal anti-mCherryTakara Bio632,543RRID:AB_2307319(1:2000)
AntibodyDonkey polyclonal anti-mouse IgGLI-COR926–032212RRID:AB_621847(1:10000)
Recombinant DNA reagentpAC6 (vector)Avidity
Recombinant DNA reagentmCherry-labeled STIM1 (plasmid)doi:10.1083/jcb.200604014
Recombinant DNA reagentOrai1-GFP (plasmid)doi:10.1074/jbc.M703573200
Peptide, recombinant proteinTEV proteaseMCLABTEV-200
Peptide, recombinant proteinBSA-biotinSigma AldrichA8549
Peptide, recombinant proteinNeutravidinThermo Fisher31000
Peptide, recombinant proteinGlucose oxidaseSigma AldrichG2133
Peptide, recombinant proteinCatalaseSigma AldrichC9322
Peptide, recombinant proteinTrypsin/LysC proteasePromegaV5071
Commercial assay or kitQuikChange IIAgilent200524
Commercial assay or kitPEG/PEG-biotinLaysan BioBIO-PEG-SVA-5K & MPEG-SVA-5K
Chemical compound, drugTCEPThermo Fisher Scientific77720
Chemical compound, drugAlexa Fluor 555Invitrogen Life TechnologiesA-20346
Chemical compound, drugAlexa Fluor 647Invitrogen Life TechnologiesA-20347
Chemical compound, drugBiotinylated lipids 18:1 Biotinyl Cap PEAvanti Polar Lipids870273 C
Chemical compound, drugegg-PC lipidsAvanti Polar Lipids840051 C
Chemical compound, drugCyclooctatetraeneSigma Aldrich138924
Chemical compound, drugBS3-d0Sigma Aldrich21590
Chemical compound, drugBS3-d4Sigma Aldrich21595
Chemical compound, drugEDCThermo Fisher Scientific77149
Chemical compound, drugSulfo-NHSThermo Fisher Scientific24520
Chemical compound, drugProteaseMaxPromegaV2071
Chemical compound, drugCyclopiazonic acid (CPA)Sigma AldrichC1530
Chemical compound, drugProtease inhibitor cocktailCell Signaling Technology5871 S
Chemical compound, drugLipofectamine 2000Thermo Scientific11668027
Chemical compound, drugPoly-D-lysineSigma AldrichP-7405
Chemical compound, drugfura-2/AMInvitrogenF-1221
Software, algorithmμManagerdoi:https://doi.org/10.1002/0471142727RRID:SCR_016865https://micro-manager.org/
Software, algorithmSMART: Single Molecule Analysis Research Tooldoi:10.1371/journal.pone.0030024https://simtk.org/projects/smart/
Software, algorithmCrystallography and NMR System (CNS)doi:10.1038/nprot.2007.406;
doi:https://doi.org/10.1107/S0907444998003254
RRID:SCR_014223http://cns-online.org/v1.2/
Software, algorithmPyMOL Molecular Graphics System ver. 1.8Schrödinger, LLCRRID:SCR_000305http://www.pymol.org/
Software, algorithmProDydoi:10.1093/bioinformatics/btr168http://prody.csb.pitt.edu/
Software, algorithmFlexpepdock server of Rosettadoi:10.1093/nar/gkr431Rosetta, RRID:SCR_015701http://flexpepdock.furmanlab.cs.huji.ac.il/
Software, algorithmByonic v2.12.0 or v2.14.27Protein MetricsRRID:SCR_016735
OtherNiNTA beadsQiagen30210
OtherSnakeSkinLife Technologies68700
OtherHiTrap Q columnGE Healthcare Life Sciences17-1153-01
OtherQuartz microscope slidesG. Finkenbeiner Inc.For smFRET
OtherMicroscope coverslipsErie Scientific24 × 40 1.5 001For smFRET
OtherLiposome Extruder SetAvanti Polar Lipids610023
OtherPC Membranes 0.1 µmAvanti Polar Lipids610005-1EA
OtherSepharose CL-4B columnSigma AldrichCL4B200
OtherOBIS 532 nm LS 150 mW laserCoherent1280719For smFRET
OtherOBIS 637 nm LX 140 mW laserCoherent1196626For smFRET
OtherDichroic beamsplitterSemrockFF652-Di01−25 × 36For smFRET
OtherDonor band-pass filterSemrockFF01-580/60-25-DFor smFRET
OtherAcceptor band-pass filterSemrockFF01-731/137-25For smFRET
OtherEmission beam splitterCairn ResearchOptoSplit-IIFor smFRET
OtherEM-CCD cameraAndoriXon DU897EFor smFRET
OtherPolychrome IITILL PhotonicsFor calcium imaging
Otheremission filterSemrockFF02-534/30-25For calcium imaging
Otheremission filter >480 nmChroma Technology Corp.For calcium imaging
OtherFlash4.0 sCMOS cameraHamamatsu Corp.For calcium imaging

Additional files

Supplementary file 1

smFRET-derived distance measurements used to construct the CC1-CAD model.

The table lists the complete set of amino acid pairs, their predominant smFRET efficiencies, the corresponding smFRET-derived distances, and the range of distance values used for generating the models shown in Figure 5A and Figure 5—figure supplement 1. The 'FRET peak' and 'Distance' values correspond to the peaks of the smFRET histograms and the associated calculated distances shown in Figure 1—figure supplements 13. For sites with both liposome and avitag measurements, the liposome measurement was used to constrain the CC1:CAD model. The ‘Range’ values indicate the allowable distance bounds for each pair of modeled residues (see Materials and methods).

https://cdn.elifesciences.org/articles/66194/elife-66194-supp1-v2.docx
Supplementary file 2

PyMOL file containing the stacked CC1-CAD models shown in Figure 5—figure supplement 1.

https://cdn.elifesciences.org/articles/66194/elife-66194-supp2-v2.pse
Supplementary file 3

PyMOL file containing the wedged CC1-CAD models shown in Figure 5—figure supplement 1.

https://cdn.elifesciences.org/articles/66194/elife-66194-supp3-v2.pse
Transparent reporting form
https://cdn.elifesciences.org/articles/66194/elife-66194-transrepform1-v2.docx

Download links